Here are four notes:
1. AlloFuse Select CM integrates osteoconductive, osteoinductive and osteogenic properties to promote and maintain bone growth.
2. The technology is intended for various spinal, neuralgic and orthopedic procedures.
3. AlloSource notes the allograft matrix is both moldable and compressible for simple insertion into interbody implants or around anatomy.
4. AlloSource’s portfolio includes AlloStem Cellular Bone Allograft, AlloFuse Cortical Fibers and AlloFuse Fiber Boat, AlloFlex Plus and AlloFuse putty, paste and gel allografts.
More articles on biologics:
Cerapedics names Antony Koblish board chair; appoints Doug Kohrs to board: 6 highlights
US regenerative medicine market to see 33% CAGR boost through 2022— 4 observations
Smith & Nephew to purchase regenerative medicine company for $210M: 3 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
